Lee Eunjee, Ito Koichi, Zhao Yong, Schadt Eric E, Irie Hanna Y, Zhu Jun
Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology.
Department of Medicine, Hematology and Medical Oncology and.
Bioinformatics. 2016 Jan 1;32(1):96-105. doi: 10.1093/bioinformatics/btv531. Epub 2015 Sep 10.
MicroRNAs (miRNAs) play a key role in regulating tumor progression and metastasis. Identifying key miRNAs, defined by their functional activities, can provide a deeper understanding of biology of miRNAs in cancer. However, miRNA expression level cannot accurately reflect miRNA activity.
We developed a computational approach, ActMiR, for identifying active miRNAs and miRNA-mediated regulatory mechanisms. Applying ActMiR to four cancer datasets in The Cancer Genome Atlas (TCGA), we showed that (i) miRNA activity was tumor subtype specific; (ii) genes correlated with inferred miRNA activities were more likely to enrich for miRNA binding motifs; (iii) expression levels of these genes and inferred miRNA activities were more likely to be negatively correlated. For the four cancer types in TCGA we identified 77-229 key miRNAs for each cancer subtype and annotated their biological functions. The miRNA-target pairs, predicted by our ActMiR algorithm but not by correlation of miRNA expression levels, were experimentally validated. The functional activities of key miRNAs were further demonstrated to be associated with clinical outcomes for other cancer types using independent datasets. For ER(-)/HER2(-) breast cancers, we identified activities of key miRNAs let-7d and miR-18a as potential prognostic markers and validated them in two independent ER(-)/HER2(-) breast cancer datasets. Our work provides a novel scheme to facilitate our understanding of miRNA. In summary, inferred activity of key miRNA provided a functional link to its mediated regulatory network, and can be used to robustly predict patient's survival.
the software is freely available at http://research.mssm.edu/integrative-network-biology/Software.html.
Supplementary data are available at Bioinformatics online.
微小RNA(miRNA)在调节肿瘤进展和转移中起关键作用。通过其功能活性鉴定关键miRNA,可以更深入地了解miRNA在癌症中的生物学特性。然而,miRNA表达水平不能准确反映miRNA活性。
我们开发了一种计算方法ActMiR,用于鉴定活性miRNA和miRNA介导的调控机制。将ActMiR应用于癌症基因组图谱(TCGA)中的四个癌症数据集,我们发现:(i)miRNA活性具有肿瘤亚型特异性;(ii)与推断的miRNA活性相关的基因更有可能富集miRNA结合基序;(iii)这些基因的表达水平与推断的miRNA活性更有可能呈负相关。对于TCGA中的四种癌症类型,我们为每种癌症亚型鉴定了77 - 229个关键miRNA,并注释了它们的生物学功能。通过我们的ActMiR算法预测但不是通过miRNA表达水平相关性预测的miRNA - 靶标对,经过实验验证。使用独立数据集进一步证明关键miRNA的功能活性与其他癌症类型的临床结果相关。对于雌激素受体阴性(ER(-))/人表皮生长因子受体2阴性(HER2(-))乳腺癌,我们鉴定了关键miRNA let - 7d和miR - 18a的活性作为潜在的预后标志物,并在两个独立的ER(-)/HER2(-)乳腺癌数据集中进行了验证。我们的工作提供了一种新的方案,以促进我们对miRNA的理解。总之,推断的关键miRNA活性为其介导的调控网络提供了功能联系,可用于可靠地预测患者的生存情况。
该软件可在http://research.mssm.edu/integrative - network - biology/Software.html免费获取。
补充数据可在《生物信息学》在线获取。